Identifying genes associated with Sorafenib resistance in hepatocellular carcinoma to develop risk model. [PDF]
He K +5 more
europepmc +1 more source
TMEM166 negatively regulates unfolded protein response to affect hepatocellular carcinoma cell growth and sorafenib resistance. [PDF]
Li T +7 more
europepmc +1 more source
FBXO2 promotes hepatocellular carcinoma progression and sorafenib resistance by targeting USP49 for proteasomal degradation. [PDF]
Hang S +6 more
europepmc +1 more source
Targeting MCM10 disrupts cancer stemness and counteracts sorafenib resistance in hepatocellular carcinoma. [PDF]
Zhang Z +9 more
europepmc +1 more source
Commentary: Transcription factor MEF2D regulates aberrant expression of ACSL3 and enhances sorafenib resistance by inhibiting ferroptosis in HCC. [PDF]
Chen X +5 more
europepmc +1 more source
Emerging trends and knowledge networks in pan-cancer sorafenib resistance: a 20-year bibliometric investigation. [PDF]
Zhou Q, Wang R.
europepmc +1 more source
PIP5K1A Suppresses Ferroptosis and Induces Sorafenib Resistance by Stabilizing NRF2 in Hepatocellular Carcinoma. [PDF]
Guo M +9 more
europepmc +1 more source
MYB Confers Sorafenib Resistance in Human Leukemia Cells via Inhibiting Ferroptosis Through FTH1 Upregulation. [PDF]
Tao X +6 more
europepmc +1 more source

